1. Medtech Insight

Boston Scientific Launches Three Interventional Cardiology Devices

A bare-metal stent approved in the U.S., a coronary-focused drug-coated balloon launched in Europe, and a global launch of a new intravascular imaging system were announced this week by Boston Scientific.

Boston Scientific Corp has announced the approval and launch of three different devices used for percutaneous coronary interventions this week, including the U.S. approval of a new bare-metal stent and the European launch of a coronary drug-coated balloon.

The firm announced PMA approval of its Rebel platinum chromium bare-metal stent July 21. It was approved specifically for de...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight

EUDAMED Notice Anticipated By September As Commission Optimizes Operations

 
• By Amanda Maxwell

The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.

Endo Tools, Fujifilm Partner to Fast-Track Endomina Rollout Across MEA Region

 
• By Shubham Singh

CEO Alexandre Chau told Medtech Insight that the Middle East and Africa presented the ideal mix of market potential, physician training opportunities, and regulatory readiness when the company was considering expansion markets beyond Europe and the US.

From Imitation To Action: Johns Hopkins Robot Autonomously Performs Key Step In Gallbladder Surgery

 
• By Marion Webb

Researchers at Johns Hopkins have used a robotic system to autonomously perform a key part of gallbladder surgery without a surgeon's hand. Lead author Axel Krieger says it could take five to 10 years before an autonomous robotic system will reach human trials and expects regulatory hurdles.